FSD Pharma to Present at the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6thBusiness Wire • 12/03/21
FSD Pharma shares pre-clinical data revealing positive effects of Lucid-MS in treating multiple sclerosis in mouse modelsProactive Investors • 12/02/21
FSD Pharma Unveils Videos Demonstrating Positive Effects of Lucid-MS in Treating Multiple Sclerosis in Pre-Clinical Models (Mouse Models)Business Wire • 12/02/21
FSD Pharma announces appointment of Dr Eleanor N. Fish to its Research and Clinical Advisory BoardProactive Investors • 11/16/21
FSD Pharma moving into psychedelic and sees legacy anti-inflammatory drug as potential coronavirus therapyProactive Investors • 11/16/21
FSD Pharma announces appointment of Eleanor N. Fish to its Research and Clinical Advisory BoardProactive Investors • 11/16/21
FSD Pharma Expands Research and Clinical Advisory Board with Appointment of World-Renowned Immunologist and Cytokine Expert Dr. Eleanor N. FishBusiness Wire • 11/16/21
FSD Pharma strikes deal with Covar Pharmaceuticals to support the development of drug candidate Lucid-PSYCHProactive Investors • 10/19/21
FSD Pharma Signs Agreement with Covar Pharmaceuticals to Support the Development of Lucid-PSYCHBusiness Wire • 10/19/21
FSD Pharma to Present at the KCSA Psychedelics Virtual Investor Conference on October 13thPRNewsWire • 10/13/21
FSD Pharma Announces Engagement with Capital Markets Communications Providers and Market MakerBusiness Wire • 09/22/21
FSD Pharma closes its all-stock acquisition of Canada's Lucid PsycheceuticalsProactive Investors • 09/21/21
Nasdaq-listed FSD Pharma To Advance Psychedelics Pipeline With $9 Million Acquisition Of Lucid PsycheceuticalsBenzinga • 08/25/21
FSD Pharma to buy pharma group Lucid Psycheceuticals in a stock deal worth US$9 millionProactive Investors • 08/25/21
FSD Pharma appoints Anthony Durkacz as its new interim chief executive officerProactive Investors • 07/27/21
FSD Pharma Inc. Announces Termination of Chief Executive Officer Dr. Raza Bokhari for CauseBusiness Wire • 07/27/21
FSD Pharma says concerned shareholder group-backed nominees elected to board at annual meetingProactive Investors • 05/17/21